Hepatitis: Clinical Trials

170 trials for Hepatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

170 unknown. 170 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4170Unknown 170

Follow Hepatitis: new trials by email Literature Review of Hepatitis trials Research Report on Hepatitis

Trials (filtered) newest first · largest first

All 170 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis
HAVRIX - Cirrhosis, Hep A
Phase 4UnknownMahidol University502024-02-292024-03-19
UHN Inpatient Hepatitis C & B Screening
Quality Improvement - Hepatitis C, Hepatitis B
Phase 4UnknownJordan Feld29202024-02-012024-02-08
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.
Hepatitis A Vaccine - Hepatitis A
Phase 4UnknownBest Healthcare Inc.3002024-01-012023-12-28
Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis
Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir - Hepatitis C, Cirrhosis
Phase 4UnknownPeking University People's Hospital1002022-09-012022-07-21
Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment
Avatrombopag, Artificial Liver Support System, Comprehensive internal medical treatment. - Thrombocytopenia, Hepatitis B, Chronic
Phase 4UnknownThird Affiliated Hospital, Sun Yat-Sen University602022-04-272022-11-10
HCV Treatment Initiation During Acute Psychiatric Admission
HCV care provided by hospitalist during acute psychiatric admission - Hepatitis C
Phase 4UnknownUniversity Health Network, Toronto542022-04-192022-05-05
Pharmacist-led Hepatitis C Management
Pharmacist-Led care, Standard of Care (Hepatology) - Hepatitis C Virus Infection
Phase 4UnknownUniversity Health Network, Toronto1082022-04-132022-04-27
Same-visit Hepatitis C Testing and Treatment (The QuickStart Study)
OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid), Sofosbuvir/Velpatasvir (Gilead) - Hepatitis C
Phase 4UnknownMacfarlane Burnet Institute for Medical Research and Public Health Ltd18002022-03-092023-11-13
The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students
20 µg dose hepatitis B vaccine - Hepatitis B Vaccine
Phase 4UnknownShanxi Medical University1502022-02-202021-12-06
Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy
Mycophenolate Mofetil, Tacrolimus - Autoimmune Hepatitis
Phase 4UnknownLeiden University Medical Center862022-01-192022-02-03
Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin
Cecolin, Hecolin - Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18
Phase 4UnknownXiamen Innovax Biotech Co., Ltd4802021-10-252022-06-13
The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China
Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir - Chronic Hepatitis C, Chronic Hepatitis B
Phase 4UnknownPeking University First Hospital1202021-08-012021-08-09
A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome
Methylprednisolone and Mycophenolate mofetil, Methylprednisolone and azathioprine - Autoimmune Hepatitis, Primary Biliary Cirrhosis
Phase 4UnknownXiaoli Fan782021-06-162021-06-21
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
Cyclosporin A, Mycophenolate Mofetil - Hepatitis, Autoimmune, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital892021-06-162021-06-22
Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides
Tenofovir Alafenamide 25 MG - Hepatitis B, Chronic
Phase 4UnknownNew Discovery LLC1002021-05-012020-11-17
Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B
Tenofovir Alafenamide fumarate 25mg Oral Tablet - Chronic Hepatitis B, Mother-to-Child Transmission
Phase 4UnknownThe First Affiliated Hospital of Zhengzhou University2402021-04-262021-04-23
Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)
antiviral prophylaxis with Tenofovir Alafenamide Fumarate - Hepatitis B, Chronic, Mother to Child Transmission
Phase 4UnknownNanfang Hospital, Southern Medical University3302021-04-042022-01-05
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
Ursodeoxycholic acid combined with total glucosides of paeony, Ursodeoxycholic acid only - Hepatitis, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital1372021-03-172021-03-24
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
Ursodeoxycholic acid, Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) - Hepatitis, Autoimmune, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital902020-11-012021-03-22
Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
Pioglitazone 15 Mg Oral Tablet, Evogliptin 5mg - Hepatitis B, Chronic, Fibrosis, Liver
Phase 4UnknownSeung Up Kim282020-09-182022-07-26

Showing 20 of 170. Sign in to see all of them.

Narrower conditions

Hepatitis B, Chronic (71)  ·  Hepatitis B (55)  ·  Hepatitis C (26)  ·  Hepatitis C, Chronic (21)  ·  Fibrosis (6)  ·  Liver Cirrhosis (6)  ·  Hepatitis, Autoimmune (5)  ·  Carcinoma, Hepatocellular (4)  ·  Hepatitis A (4)  ·  Liver Cirrhosis, Biliary (4)  ·  Coinfection (3)  ·  Hepatitis, Alcoholic (3)  ·  Liver Diseases, Alcoholic (3)  ·  Acquired Immunodeficiency Syndrome (2)

Broader conditions

Digestive System Diseases (169)  ·  Liver Diseases (169)  ·  Hepatitis, Viral, Human (156)  ·  Infections (156)  ·  Virus Diseases (156)  ·  Blood-Borne Infections (151)  ·  Communicable Diseases (151)  ·  DNA Virus Infections (113)  ·  Hepadnaviridae Infections (112)  ·  Pathological Conditions, Signs and Symptoms (108)  ·  Pathologic Processes (107)  ·  Hepatitis, Chronic (96)  ·  Disease Attributes (95)  ·  Chronic Disease (93)

Interventions

entecavir (36)  ·  peginterferon alfa-2a (23)  ·  Tenofovir (15)  ·  Ribavirin (12)  ·  Telbivudine (10)  ·  Lamivudine (9)  ·  adefovir (8)  ·  tenofovir alafenamide (8)  ·  adefovir dipivoxil (7)  ·  sofosbuvir-velpatasvir drug combination (6)  ·  Emtricitabine (5)  ·  Mycophenolic Acid (5)  ·  Sofosbuvir (5)  ·  peginterferon alfa-2b (5)  ·  velpatasvir (5)

Sponsors

National Taiwan University Hospital (11)  ·  Third Affiliated Hospital, Sun Yat-Sen University (8)  ·  Nanfang Hospital, Southern Medical University (6)  ·  Asian-Pacific Alliance of Liver Disease, Beijing (5)  ·  Beijing Ditan Hospital (5)  ·  Yonsei University (5)  ·  Beijing 302 Hospital (4)  ·  Shanxi Medical University (4)  ·  University Health Network, Toronto (4)  ·  West China Hospital (4)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (3)  ·  Ruijin Hospital (3)  ·  Asan Medical Center (2)  ·  IlDong Pharmaceutical Co Ltd (2)  ·  Instituto de Investigación Marqués de Valdecilla (2)

Countries

China (61)  ·  Taiwan (19)  ·  South Korea (15)  ·  United States (8)  ·  Canada (6)  ·  Egypt (4)  ·  Spain (4)  ·  India (3)  ·  Italy (3)  ·  Netherlands (3)  ·  Thailand (3)  ·  Belgium (2)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)

Top investigators

Jun Cheng, M.D. (5)  ·  Pei-Jer Chen, M.D., Ph.D. (3)  ·  Suping Wang, PhD (3)  ·  Alejandro Soza, MD (2)  ·  Calvin Q Pan, MD (2)  ·  Chen-Hua Liu, MD (2)  ·  Cheng-Chao Liang, MD (2)  ·  Chih-Lin Lin, MD (2)  ·  Ching-Sheng Hsu, MD (2)  ·  Gamal Esmat, MD (2)  ·  Jia-Horng Kao, MD, PhD (2)  ·  Jinlin Hou (2)  ·  Jinlin Hou, MD (2)

Results publications

PMID 19187608, PMID 21182232, PMID 22436845, PMID 23046671, PMID 23518903, PMID 24915612, PMID 25348661, PMID 42349783, PMID 10051494, PMID 10613747, PMID 11855555, PMID 12019083, PMID 12606735, PMID 14697813, PMID 15014185, PMID 15470215, PMID 15985009, PMID 15987917, PMID 16164651, PMID 16525137, PMID 16708058, PMID 17377504, PMID 18094378, PMID 19027013, PMID 19052126, PMID 19376603, PMID 19729084, PMID 20049753, PMID 20220333, PMID 2023605, PMID 20377423, PMID 2142748, PMID 21677438, PMID 21701902, PMID 22045673, PMID 22273662, PMID 22371643, PMID 23150796, PMID 23219442, PMID 23245604, PMID 23449768, PMID 23689577, PMID 24189358, PMID 24375637, PMID 24583931, PMID 24843060, PMID 24954675, PMID 25190434, PMID 25381721, PMID 25643863

NIH funding

2005 (1)